Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Watsonville › NPI 1710958228
Hospital

Watsonville Hospital Corporation

Watsonville Hospital Corporation was paid $23.00M by Medicaid between Jan 2018 and Feb 2024, across 191 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 30% of everything it billed.

33Billing provider infoWATSONVILLE HOSPITAL CORPORATION
WATSONVILLE, CA 95076
33aNPI1710958228assigned 02/01/2006
28Total paid$23.00M
24GClaims537,230
24DCodes billed191
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#111 of 410
Median peer was paid$6.90M
This provider vs. median3.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018102,224$3.86M
2019104,387$4.03M
202074,487$3.23M
202191,905$4.08M
2022111,527$5.25M
202352,570$2.55M
2024incomplete130$4K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99281 Emergency department visit for the evaluation and management, self-limited or minor 30% 86,106 76,764 $6.88M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.6% 4,244 4,160 $1.06M
77067 Screening mammography, bilateral, including computer-aided detection 4.4% 7,099 7,094 $1.01M
70450 Computed tomography, head or brain; without contrast material 3.5% 4,352 4,241 $806K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.2% 9,635 9,010 $740K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2.8% 9,534 9,140 $633K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.2% 12,829 11,384 $503K
76700 Ultrasound, abdominal, real time with image documentation; complete 2.1% 4,975 4,949 $472K
96361 Intravenous infusion, hydration; each additional hour 2.0% 9,597 8,981 $452K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 4,298 4,051 $426K
Z7502 1.6% 9,886 9,684 $367K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.6% 3,149 3,018 $366K
179 more codes
96375 Therapeutic injection; each additional sequential IV push 1.6% 6,763 $357K
80053 Comprehensive metabolic panel 1.5% 25,565 $340K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 4,856 $335K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.4% 9,294 $315K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.3% 3,797 $302K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.3% 3,560 $302K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 28,098 $274K
99213 Doctor's office visit, returning patient (routine) 1.1% 1,653 $264K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.1% 6,556 $260K
76830 Ultrasound, transvaginal 1.1% 3,018 $254K
77063 Screening digital breast tomosynthesis, bilateral 1.1% 6,818 $247K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 1.1% 460 $245K
97535 Self-care/home management training, each 15 minutes 1.1% 7,237 $244K
71046 Radiologic examination, chest; 2 views 1.0% 10,766 $231K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.0% 2,366 $230K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,855 $216K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 316 $203K
72125 Computed tomography, cervical spine; without contrast material <1% 652 $178K
70551 Magnetic resonance imaging, brain; without contrast material <1% 280 $172K
93976 <1% 587 $155K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 785 $151K
93971 <1% 1,069 $141K
59025 Fetal non-stress test <1% 2,538 $131K
76770 <1% 1,428 $127K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,112 $125K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 59,762 $119K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,157 $116K
76642 <1% 1,578 $113K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,447 $112K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,266 $107K
V5008 Hearing screening <1% 1,498 $104K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,540 $91K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,557 $87K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 180 $84K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,133 $84K
81025 <1% 8,412 $78K
84484 <1% 5,634 $78K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,858 $75K
83690 <1% 8,463 $73K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 3,270 $69K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,433 $68K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,317 $67K
83605 <1% 4,719 $66K
71275 Computed tomographic angiography, chest, with contrast material <1% 282 $62K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 220 $62K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 995 $61K
73562 <1% 2,086 $59K
81001 <1% 14,372 $58K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 206 $58K
73610 <1% 1,653 $57K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,663 $52K
73030 <1% 1,641 $52K
73630 <1% 1,474 $48K
72110 <1% 733 $39K
86141 <1% 2,569 $37K
0450 Emergency room services <1% 888 $37K
73130 <1% 1,020 $36K
73564 <1% 1,069 $36K
87040 <1% 2,522 $36K
87186 <1% 2,997 $35K
71045 Radiologic examination, chest; single view <1% 3,442 $35K
Z7610 <1% 2,889 $33K
84443 Thyroid stimulating hormone (TSH) <1% 1,436 $30K
73110 <1% 886 $30K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,263 $30K
99156 <1% 473 $29K
77066 Tomosynthesis, mammo <1% 171 $28K
87077 <1% 2,926 $28K
77065 Tomosynthesis, mammo <1% 242 $27K
87634 <1% 281 $25K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 252 $24K
83880 <1% 872 $24K
83735 <1% 2,835 $24K
72100 <1% 667 $23K
82962 <1% 5,670 $23K
93017 <1% 441 $23K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 779 $23K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 781 $23K
81002 <1% 5,066 $23K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 785 $23K
76801 <1% 264 $22K
76536 <1% 279 $20K
J2785 Injection, regadenoson, 0.1 mg <1% 82 $20K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 2,274 $20K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,254 $18K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,823 $18K
80061 Lipid panel <1% 954 $17K
73502 <1% 567 $17K
84702 <1% 838 $17K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,938 $17K
74018 <1% 665 $16K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,070 $16K
73080 <1% 440 $16K
80048 Basic metabolic panel (calcium, ionized) <1% 1,433 $15K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,350 $15K
86403 <1% 514 $15K
85379 <1% 1,031 $13K
87400 <1% 1,661 $11K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 118 $11K
90715 <1% 203 $10K
82652 <1% 201 $10K
85610 <1% 1,998 $10K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 98 $9K
J2060 Injection, lorazepam, 2 mg <1% 1,166 $9K
Z9725 <1% 189 $8K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,115 $8K
83036 Hemoglobin; glycosylated (A1C) <1% 573 $7K
82570 <1% 950 $7K
86901 <1% 1,709 $7K
77080 <1% 153 $7K
80069 <1% 544 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 66 $6K
86850 <1% 539 $6K
84466 <1% 330 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 626 $6K
J2270 Injection, morphine sulfate, up to 10 mg <1% 470 $5K
85730 <1% 738 $5K
J7030 Infusion, normal saline solution , 1000 cc <1% 471 $5K
82728 <1% 274 $5K
93350 <1% 53 $4K
73140 <1% 191 $4K
72050 <1% 94 $4K
82247 <1% 523 $4K
93970 <1% 25 $4K
87420 <1% 201 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 187 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 429 $3K
84156 <1% 718 $3K
83540 <1% 331 $3K
87088 <1% 225 $3K
86900 <1% 651 $2K
83655 <1% 147 $2K
S0164 Injection, pantoprazole sodium, 40 mg <1% 149 $2K
80179 <1% 115 $2K
82043 <1% 265 $2K
72040 <1% 60 $2K
87070 <1% 161 $2K
85651 <1% 350 $2K
Z9726 <1% 40 $2K
84100 <1% 275 $2K
74021 <1% 49 $2K
72072 <1% 36 $2K
82248 <1% 209 $2K
73590 <1% 38 $1K
J2358 Injection, olanzapine, long-acting, 1 mg <1% 91 $1K
99283 Emergency room visit (moderate) <1% 25 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 131 $1K
76775 <1% 14 $1K
76881 <1% 15 $946.96
84439 <1% 81 $944.17
73090 <1% 31 $858.19
96523 <1% 38 $831.54
J3475 Injection, magnesium sulfate, per 500 mg <1% 66 $678.76
87806 <1% 15 $609.45
84550 <1% 92 $553.94
Z7500 <1% 15 $511.50
J3410 Injection, hydroxyzine hcl, up to 25 mg <1% 15 $481.92
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 13 $407.00
82150 <1% 44 $362.49
82550 <1% 49 $355.30
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 42 $347.56
84145 <1% 12 $344.30
85027 <1% 38 $334.07
87147 <1% 27 $323.89
73560 <1% 12 $292.71
97014 <1% 66 $259.37
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 42 $257.56
73660 <1% 12 $247.17
J7050 Infusion, normal saline solution, 250 cc <1% 30 $240.00
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 123 $180.02
J3490 Unclassified drugs <1% 33 $179.33
J3010 Injection, fentanyl citrate, 0.1 mg <1% 117 $174.63
J0690 Injection, cefazolin sodium, 500 mg <1% 13 $139.08
84703 <1% 12 $128.26
J2550 Injection, promethazine hcl, up to 50 mg <1% 13 $119.56
96379 <1% 1,396 $106.99
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 12 $0.00
36415 Collection of venous blood by venipuncture 0% 88 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICHARDSON, TARA (VP PATIENT FINANCIAL SERVICES)
Same official

Other billing entities under RICHARDSON, TARA

Full network →
ProviderLocationPaid
Granite City Illinois Hospital Company LLCGranite City, IL$1.09M
DHSC LLCMassillon, OH$186K
Big Bend Hospital CorporationAlpine, TX$177K
National Healthcare of MT Vernon INCMount Vernon, IL$105K
Galesburg Hospital CorporationGalesburg, IL$99K
Centre Hospital CorporationCentre, AL$30K
Jackson Hospital CorporationCampton, KY$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.